- 1) Hirano, S., Seino, H., Akiyama, Y., and Nonaka, I., Chitosan: a biocompatible material for oral and intravenous administration. In “Progress in Biomedical Polymers”, eds. Gebelein, C. G., and Dunn, R. L., Plenum Press, New York, pp. 238–290 (1990).
- 2) Aspden, T. J., Mason, J. D. T., Jones, N. S., Lowe, J., Skaugrud, O., and Illum, L., Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J. Pharm. Sci., 86, 509–513 (1997).
- 3) Dodane, V., and Vilivalam, V. D., Pharmaceutical applications of chitosan. Pharm. Sci. Technol. To., 1, 246–253 (1998).
- 4) Paul, W., and Sharma, C. P., Chitosan, a drug carrier for the 21st century: a review. STP Pharma. Sci., 10, 5–22 (2000).
- 5) Thanou, M., Verhoef, J. C., and Junginger, H. E., Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliver. Rev., 52, 117–126 (2001).
- 6) Hassan, E. E., Parish, R. C., and Gallo, J. M., Optimized formulation of magnetic chitosan microspheres containing the anticancer agent. Pharm. Res., 9, 390–397 (1992).
- 7) Thanoo, B. C., Sunny, M. C., and Jayakrishnan, A., Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol., 44, 283–286 (1992).
- 8) Akbuga, J., and Durmaz, G., Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int. J. Pharm., 111, 217–222 (1994).
- 9) Berthold, A., Cremer, K., and Kreuter, J., Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres. STP Pharma. Sci., 6, 358–364 (1996).
- 10) Dumitriu, S., and Chornet, E., Inclusion and release of proteins from polysaccharide-based polyion complexes. Adv. Drug Deliver. Rev., 31, 223–246 (1998).
- 11) Janes, K. A., Calvo, P., and Alonso, M. J., Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliver. Rev., 47, 83–97 (2001).
- 12) Alonso, M. J., and Sanchez, A., The potential of chitosan in ocular drug delivery. J. Pharm. Pharmacol., 55, 1451–1463 (2003).
- 13) Mao, H. Q., Roy, K., Troung-Le, V. L., Janes, K. A., Lin, K. Y., Wang, Y., August, J. T., and Leong, K. W., Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release, 70, 399–421 (2001).
- 14) Cui, Z. R., and Mumper, R. J., Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release, 75, 409–419 (2001).
- 15) Bozkir, A., and Saka, O. M., Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv., 11, 107–112 (2004).
- 16) Liu, W., Sun, S., Cao, Z., Zhang, X., Yao, K., Lu, W. W., and Luk, K. D. K., An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials, 26, 2705–2711 (2005).
- 17) Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., and Alonso, M. J., Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release, 73, 255–267 (2001).
- 18) De Campos, A. M., Sanchez, A., and Alonso, M. J., Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface: Application to cyclosporin A. Int. J. Pharm., 224, 159–168 (2001).
- 19) Ohya, Y., Shiratani, M., Kobayashi, H., and Ouchi, T., Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell-specific cytotoxicity. J. Macromol. Sci. Pure Appl. Chem., A31, 629–642 (1994).
- 20) Bodmeier, R., Chen, H. G., and Paeratakul, O., A novel approach to the oral delivery of micro- or nanoparticles. Pharm. Res., 6, 413–417 (1989).
- 21) Xu, Y. M., and Du, Y. M., Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm., 250, 215–226 (2003).
- 22) Janes, K. A., and Alonso, M. J., Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. J. Appl. Polym. Sci., 88, 2769–2776 (2003).
- 23) Chang, T. C., Wang, J. W., and Hon, M. H., Synthesis of nanosized chitosan-poly(acrylic acid) particles by a dropping method. Macromol. Biosci., 4, 416–420 (2004).
- 24) Wang, W., Bo, S., Li, S., and Qin, W., Determination of the Mark–Houwink equation for chitosans with different degrees of deacetylation. Int. J. Biol. Macromol., 13, 281–285 (1991).
- 25) Miya, M., Iwamoto, R., Yoshikawa, S., and Mima, S., I.r. spectroscopic determination of CONH content in highly deacylated chitosan. Int. J. Biol. Macromol., 2, 323–324 (1980).
- 26) Guisan, J. M., Aldehyde-agarose gels as activated supports for immobilization-stabilization of enzymes. Enzyme Microb. Technol., 10, 375–382 (1988).
- 27) Ichikawa, S., Takano, K., Kuroiwa, T., Hiruta, O., Sato, S., and Mukataka, S., Immobilization and stabilization of chitosanase by multipoint attachment to agar gel support. J. Biosci. Bioeng., 93, 201–206 (2002).
- 28) Kuroiwa, T., Ichikawa, S., Hiruta, O., Sato, S., and Mukataka, S., Factors affecting the composition of oligosaccharides produced in chitosan hydrolysis using immobilized chitosanases. Biotechnol. Progress, 18, 969–974 (2002).
- 29) Muzzarelli, R. A. A., “Chitin”, Pergamon Press, Oxford, p. 105 (1977).
- 30) Rinaudo, M., and Milas, M., Interaction of monovalent and divalent counterions with some carboxylic polysaccharides. J. Polym. Sci. Polym. Chem. Ed., 12, 2073–2081 (1974).
- 31) Tsuchida, E., Formation of polyelectrolyte complexes and their structures. J. Macromol. Sci. Pure Appl. Chem., A31, 1–15 (1994).
- 32) Watanabe, J., Iwamoto, S., and Ichikawa, S., Entrapment of some compounds into biocompatible nano-sized particles and their releasing properties. Colloids Surfaces B, 42, 141–146 (2005).
Bioscience, Biotechnology, and Biochemistry
Volume 69, 2005 - Issue 9